Preventing Drugs and Substance Abuse in Youth

This policy brief is about preventing drugs and substance abuse in teens. It talks about why kids start using drugs, like peer pressure, stress, or family issues, and explains how schools, families, and communities can help stop it.

Published by

Sohum Shah

October 21, 2026

Read

Visit Website

Download PDF

Inquiry-driven, this project may reflect personal views, aiming to enrich problem-related discourse.

HeadingHeading 3

Other Fellowship Capstones

Healthcare Reform in America's Prisons

Capstones Summer 2025

Taylor Howard

As mass incarceration continues to rise in the United States, ethical and legal concerns regarding healthcare administration and quality in America’s prisons have become increasingly prevalent. Given that incarcerated individuals have a constitutionally protected right to adequate healthcare, policy makers and government officials have both an ethical and a legal obligation to implement reforms that will enable prisons to provide constitutionally adequate healthcare systems that protect the health and rights of incarcerated persons.

The Uneven Distribution of Government Assistance Programs Across American Regions

Capstones - Spring 2026

Zoey Smith

This paper examines how government assistance is not evenly dispersed across American regions. The issue is caused by state-level management of federally funded programs that lead to major differences in welfare access and effectiveness.

The Price of Staying Alive: The U.S. Government’s Role in Regulating Life-Saving Medicines

Capstones - Spring 2023

Kayleigh McArdle

This brief delves into the alarming rise of life-saving drug prices in the U.S., particularly focusing on insulin and Epi-Pens, and explores the role of insurance companies and manufacturers in this hike.

Card Title

Card Title

Card Title

Card Title

Other Fellowship Capstones

Healthcare Reform in America's Prisons

The Uneven Distribution of Government Assistance Programs Across American Regions

The Price of Staying Alive: The U.S. Government’s Role in Regulating Life-Saving Medicines